DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Potent Human α-Amylase Inhibition by the β-Defensin-like Protein Helianthamide

Abstract

Here, selective inhibitors of human pancreatic α-amylase (HPA) are an effective means of controlling blood sugar levels in the management of diabetes. A high-throughput screen of marine natural product extracts led to the identification of a potent (Ki = 10 pM) peptidic HPA inhibitor, helianthamide, from the Caribbean sea anemone Stichodactyla helianthus. Active helianthamide was produced in Escherichia coli via secretion as a barnase fusion protein. X-ray crystallographic analysis of the complex of helianthamide with porcine pancreatic α-amylase revealed that helianthamide adopts a β-defensin fold and binds into and across the amylase active site, utilizing a contiguous YIYH inhibitory motif. Helianthamide represents the first of a novel class of glycosidase inhibitors and provides an unusual example of functional malleability of the β-defensin fold, which is rarely seen outside of its traditional role in antimicrobial peptides.

Authors:
 [1];  [2];  [3];  [2];  [4];  [4];  [4];  [2];  [1];  [1];  [3];  [2];  [5]
  1. Centre for High-Throughput Biology, Michael Smith Laboratories, 185 East Mall, Vancouver, British Columbia V6T 1Z4, Canada
  2. Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada
  3. Department of Chemistry, University of British Columbia, 2036 Main Mall, Vancouver, British Columbia V6T 1Z1, Canada, Department of Earth and Ocean Sciences, University of British Columbia, Vancouver, British Columbia V6T 1Z4, Canada
  4. Department of Chemistry, University of British Columbia, 2036 Main Mall, Vancouver, British Columbia V6T 1Z1, Canada
  5. Centre for High-Throughput Biology, Michael Smith Laboratories, 185 East Mall, Vancouver, British Columbia V6T 1Z4, Canada, Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada, Department of Chemistry, University of British Columbia, 2036 Main Mall, Vancouver, British Columbia V6T 1Z1, Canada
Publication Date:
Research Org.:
SLAC National Accelerator Laboratory (SLAC), Menlo Park, CA (United States)
Sponsoring Org.:
USDOE Office of Science (SC), Biological and Environmental Research (BER); USDOE Office of Science (SC), Basic Energy Sciences (BES)
OSTI Identifier:
1239610
Alternate Identifier(s):
OSTI ID: 1244269
Grant/Contract Number:  
AC02-76SF00515; 111082; P41GM103393
Resource Type:
Published Article
Journal Name:
ACS Central Science
Additional Journal Information:
Journal Name: ACS Central Science Journal Volume: 2 Journal Issue: 3; Journal ID: ISSN 2374-7943
Publisher:
American Chemical Society
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES

Citation Formats

Tysoe, Christina, Williams, Leslie K., Keyzers, Robert, Nguyen, Nham T., Tarling, Chris, Wicki, Jacqueline, Goddard-Borger, Ethan D., Aguda, Adeleke H., Perry, Suzanne, Foster, Leonard J., Andersen, Raymond J., Brayer, Gary D., and Withers, Stephen G. Potent Human α-Amylase Inhibition by the β-Defensin-like Protein Helianthamide. United States: N. p., 2016. Web. doi:10.1021/acscentsci.5b00399.
Tysoe, Christina, Williams, Leslie K., Keyzers, Robert, Nguyen, Nham T., Tarling, Chris, Wicki, Jacqueline, Goddard-Borger, Ethan D., Aguda, Adeleke H., Perry, Suzanne, Foster, Leonard J., Andersen, Raymond J., Brayer, Gary D., & Withers, Stephen G. Potent Human α-Amylase Inhibition by the β-Defensin-like Protein Helianthamide. United States. https://doi.org/10.1021/acscentsci.5b00399
Tysoe, Christina, Williams, Leslie K., Keyzers, Robert, Nguyen, Nham T., Tarling, Chris, Wicki, Jacqueline, Goddard-Borger, Ethan D., Aguda, Adeleke H., Perry, Suzanne, Foster, Leonard J., Andersen, Raymond J., Brayer, Gary D., and Withers, Stephen G. Fri . "Potent Human α-Amylase Inhibition by the β-Defensin-like Protein Helianthamide". United States. https://doi.org/10.1021/acscentsci.5b00399.
@article{osti_1239610,
title = {Potent Human α-Amylase Inhibition by the β-Defensin-like Protein Helianthamide},
author = {Tysoe, Christina and Williams, Leslie K. and Keyzers, Robert and Nguyen, Nham T. and Tarling, Chris and Wicki, Jacqueline and Goddard-Borger, Ethan D. and Aguda, Adeleke H. and Perry, Suzanne and Foster, Leonard J. and Andersen, Raymond J. and Brayer, Gary D. and Withers, Stephen G.},
abstractNote = {Here, selective inhibitors of human pancreatic α-amylase (HPA) are an effective means of controlling blood sugar levels in the management of diabetes. A high-throughput screen of marine natural product extracts led to the identification of a potent (Ki = 10 pM) peptidic HPA inhibitor, helianthamide, from the Caribbean sea anemone Stichodactyla helianthus. Active helianthamide was produced in Escherichia coli via secretion as a barnase fusion protein. X-ray crystallographic analysis of the complex of helianthamide with porcine pancreatic α-amylase revealed that helianthamide adopts a β-defensin fold and binds into and across the amylase active site, utilizing a contiguous YIYH inhibitory motif. Helianthamide represents the first of a novel class of glycosidase inhibitors and provides an unusual example of functional malleability of the β-defensin fold, which is rarely seen outside of its traditional role in antimicrobial peptides.},
doi = {10.1021/acscentsci.5b00399},
journal = {ACS Central Science},
number = 3,
volume = 2,
place = {United States},
year = {Fri Feb 26 00:00:00 EST 2016},
month = {Fri Feb 26 00:00:00 EST 2016}
}